News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Bloom Energy plunged intraday while raising Q4 revenue guidance to $1.35–$1.55 billion and reporting 138% YoY revenue growth.
  • Company cites a multi-billion backlog tied to AI data centers supporting its near-term revenue outlook.
  • UiPath flagged as a buy amid AI-driven weakness, with ARR growth, free cash flow, and GAAP profitability cited.
  • Trade plan for UiPath: entry $13.51, stop $11.50, target $17.00 over about 45 trading days.
  • Traders emphasize strict stop-loss levels to manage risk amid AI-related volatility in these names.
  • AI demand for data centers is driving selective risk-on flows into energy and enterprise software equities.

Latest Articles

WISeQey’s Subsidiary WISeSat.Space, a Space Technology Company, Completes Business Combination with Columbus Acquisition Corporation

WISeQey’s Subsidiary WISeSat.Space, a Space Technology Company, Completes Business Combination with Columbus Acquisition Corporation

WISeSat.Space, a subsidiary of WISeQey Corp., completed its business combination with Columbus Acquisition Corporation and began trading on Nasdaq under ticker symbol SAIQ. This marks WISeSat.Space as a publicly-listed company focused on post-quantum-secure satellite communications and IoT connectivity. The listing supports the company's mission to…

Natural Gas Pins Price Between Moving Averages After Bounce From $2.966 Fib

Natural Gas Pins Price Between Moving Averages After Bounce From $2.966 Fib

Natural Gas is trading at $3.037 on the 5-hour chart and is compressed between the 20-period and 50-period simple moving averages, while resting beneath the Ichimoku cloud. The market recently rebounded off the $2.966 Fibonacci support on rising volume. Short-term directional risk hinges on a breakout above the cloud around $3.06 or a breakdown bel…

GitLab Trade Idea: Ride Flex Pricing and AI-Fueled ARR Acceleration

GitLab Trade Idea: Ride Flex Pricing and AI-Fueled ARR Acceleration

GitLab's recent results and product shifts - notably Flex pricing and AI-driven feature demand - have accelerated ARR growth to 42% and produced clear upside in large customer deals. The business is trading at an attractive setup relative to sentiment but needs to prove margin stability. This trade idea presents a mid-term swing to capture continue…

Buy the Dip: Accenture's AI Win Turns a Beat Into a Strategic Re-rating

Buy the Dip: Accenture's AI Win Turns a Beat Into a Strategic Re-rating

Accenture reported stronger-than-expected Q4 results driven by broad AI adoption and margin expansion. The combination of $18.7B quarterly revenue, a jump in operating margins to 15.3%, and management's FY2027 guidance plus aggressive capital allocation creates a near-term trade opportunity. I recommend initiating a long position on a dip with a $2…

Biogen’s Litifilimab Demonstrates Rapid and Durable Efficacy in New 52-Week Phase 2 Data from Ongoing Phase 2/3 AMETHYST Study, Reinforcing Its Potential as a First-in-Class Therapy for Cutaneous Lupus Erythematosus

Biogen’s Litifilimab Demonstrates Rapid and Durable Efficacy in New 52-Week Phase 2 Data from Ongoing Phase 2/3 AMETHYST Study, Reinforcing Its Potential as a First-in-Class Therapy for Cutaneous Lupus Erythematosus

Biogen Inc. announced encouraging 52-week Phase 2 data from its ongoing AMETHYST Phase 2/3 study of litifilimab, an investigational therapy for cutaneous lupus erythematosus (CLE). Results show continued and rapid improvement in skin symptoms, with over 27% of patients achieving clear or almost clear skin, and a consistent safety profile. The FDA g…